rs878854780
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_ModerateBP6_ModerateBP7
The NM_005670.4(EPM2A):c.210G>A(p.Glu70Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000336 in 1,488,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000030 ( 0 hom. )
Consequence
EPM2A
NM_005670.4 synonymous
NM_005670.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.58
Publications
0 publications found
Genes affected
EPM2A (HGNC:3413): (EPM2A glucan phosphatase, laforin) This gene encodes a dual-specificity phosphatase and may be involved in the regulation of glycogen metabolism. The protein acts on complex carbohydrates to prevent glycogen hyperphosphorylation, thus avoiding the formation of insoluble aggregates. Loss-of-function mutations in this gene have been associated with Lafora disease, a rare, adult-onset recessive neurodegenerative disease, which results in myoclonus epilepsy and usually results in death several years after the onset of symptoms. The disease is characterized by the accumulation of insoluble particles called Lafora bodies, which are derived from glycogen. [provided by RefSeq, Jan 2018]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 6-145735289-C-T is Benign according to our data. Variant chr6-145735289-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 240199.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=2.58 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000662 AC: 1AN: 151092Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
151092
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000187 AC: 2AN: 106876 AF XY: 0.0000336 show subpopulations
GnomAD2 exomes
AF:
AC:
2
AN:
106876
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000299 AC: 4AN: 1337054Hom.: 0 Cov.: 30 AF XY: 0.00000606 AC XY: 4AN XY: 660140 show subpopulations
GnomAD4 exome
AF:
AC:
4
AN:
1337054
Hom.:
Cov.:
30
AF XY:
AC XY:
4
AN XY:
660140
show subpopulations
African (AFR)
AF:
AC:
0
AN:
27126
American (AMR)
AF:
AC:
3
AN:
30804
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
22976
East Asian (EAS)
AF:
AC:
0
AN:
29496
South Asian (SAS)
AF:
AC:
0
AN:
75128
European-Finnish (FIN)
AF:
AC:
0
AN:
41888
Middle Eastern (MID)
AF:
AC:
0
AN:
5144
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1049904
Other (OTH)
AF:
AC:
1
AN:
54588
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00000662 AC: 1AN: 151092Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73760 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
151092
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
73760
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41326
American (AMR)
AF:
AC:
1
AN:
15182
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3452
East Asian (EAS)
AF:
AC:
0
AN:
5144
South Asian (SAS)
AF:
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
AC:
0
AN:
10274
Middle Eastern (MID)
AF:
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
AC:
0
AN:
67586
Other (OTH)
AF:
AC:
0
AN:
2068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Progressive myoclonic epilepsy Benign:1
Jun 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.